Can a short daily workout help hospitalized diabetes patients?

NCT ID NCT06547541

Terminated Symptom relief Sponsor: Rigshospitalet, Denmark Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether hospitalized adults with type 2 diabetes or prediabetes could safely do 30 minutes of resistance training each day. The goal was to see if this exercise routine is feasible and if it helps control blood sugar and prevent muscle loss during a hospital stay. Only 4 people took part before the study was stopped early, so the results are very limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: resistance training (body weight exercises)
What this could lead to: If successful, this could show that simple in-hospital exercise helps manage blood sugar and muscle loss in type 2 diabetes patients.
What could go wrong: This is a very small, early feasibility study (only 4 participants enrolled) and was terminated early, so results are limited and may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Motor Activity prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2 PREDIABETES PREDIABETES OR DIABETES

Contacts and locations

Locations

Copenhagen University Hospital

Copenhagen, Capitol Region of Denmark, 2100, Denmark
Departement of Infectious Diseases - Hvidovre Hospital

Copenhagen, Capitol Region of Denmark, 2650, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.